Wolfe Research Initiates Coverage On Denali Therapeutics with Peer Perform Rating
Benzinga Newsdesk 8 months ago
NewsInitiationAnalyst Ratings
Wolfe Research analyst Rudy Li initiates coverage on Denali Therapeutics (NASDAQ:DNLI) with a Peer Perform rating.
Wolfe Research analyst Rudy Li initiates coverage on Denali Therapeutics (NASDAQ:DNLI) with a Peer Perform rating.